Momenta Pharmaceuticals Analysis
Momenta Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Momenta Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Momenta Pharmaceuticals is worth, separate from its market price. There are two main types of Momenta Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Momenta Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Momenta Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Momenta Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Momenta Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Momenta Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Momenta Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Momenta |
Momenta Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.21. Momenta Pharmaceuticals recorded a loss per share of 2.09. The entity had not issued any dividends in recent years. Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases in the United States. As of September 30, 2020, Momenta Pharmaceuticals, Inc. operates as a subsidiary of Johnson Johnson. Momenta Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 118 people. To find out more about Momenta Pharmaceuticals contact Craig Wheeler at 617 621-0431 or learn more at www.momentapharma.com.Momenta Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Momenta Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Momenta Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Momenta Pharmaceuticals is not yet fully synchronised with the market data | |
| Momenta Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Momenta Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 30.07 M. Net Loss for the year was (227.83 M) with loss before overhead, payroll, taxes, and interest of (73.76 M). | |
| Momenta Pharmaceuticals currently holds about 436.3 M in cash with (199.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.75. | |
| Over 99.0% of the company shares are owned by institutional investors |
Momenta Pharmaceuticals Thematic Classifications
In addition to having Momenta Pharmaceuticals stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
Momenta Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Momenta Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Momenta Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Momenta Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Momenta Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Momenta Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Momenta Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Craig Wheeler over a year ago Momenta Pharmaceuticals exotic insider transaction detected |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Momenta Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Momenta Stock
If you are still planning to invest in Momenta Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Momenta Pharmaceuticals' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |